The numerous predicted Myb binding sites in TSS2 suggest that once Myb becomes expressed in ACC tumors, a stimulatory loop may exist, allowing Myb to keep its own gene activated through the TSS2 promoter. The gene discussed is MYB; the disease is adrenal cortex carcinoma.